| __timestamp | Rhythm Pharmaceuticals, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 10811000 |
| Thursday, January 1, 2015 | 3425000 | 33001000 |
| Friday, January 1, 2016 | 6311000 | 64936000 |
| Sunday, January 1, 2017 | 9518000 | 99909000 |
| Monday, January 1, 2018 | 28080000 | 127724000 |
| Tuesday, January 1, 2019 | 36550000 | 161524000 |
| Wednesday, January 1, 2020 | 46125000 | 182933000 |
| Friday, January 1, 2021 | 68486000 | 219982000 |
| Saturday, January 1, 2022 | 92032000 | 278139000 |
| Sunday, January 1, 2023 | 117532000 | 309799000 |
Cracking the code
In the competitive world of biotechnology, managing costs is crucial for success. This analysis of SG&A (Selling, General, and Administrative) expenses from 2014 to 2023 for Ultragenyx Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc. reveals intriguing trends. Over this period, Ultragenyx consistently outpaced Rhythm in SG&A spending, with a peak in 2023 where Ultragenyx's expenses were nearly 2.6 times higher than Rhythm's. This reflects Ultragenyx's aggressive growth strategy, investing heavily in administrative and sales functions to support its expanding portfolio. Meanwhile, Rhythm's more conservative approach saw a steady increase, culminating in a tenfold rise from 2014 to 2023. These insights highlight the diverse strategies within the biotech sector, where balancing cost management with growth ambitions is key. As the industry evolves, monitoring such financial metrics will be essential for stakeholders aiming to understand and predict market dynamics.
Gilead Sciences, Inc. vs Rhythm Pharmaceuticals, Inc.: SG&A Expense Trends
Biogen Inc. and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.
Exelixis, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Blueprint Medicines Corporation and Ultragenyx Pharmaceutical Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
Ultragenyx Pharmaceutical Inc. and Novavax, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared